AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets close in 6 hrs 25 mins

Allergan plc (AGN)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
213.81-2.33 (-1.08%)
As of 9:35AM EST. Market open.
People also watch
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close216.14
Open214.40
Bid0.00 x
Ask0.00 x
Day's Range213.22 - 214.66
52 Week Range184.50 - 301.98
Volume94,786
Avg. Volume5,263,304
Market Cap80.2B
Beta1.12
PE Ratio (TTM)6.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (1.30%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids

    DUBLIN and BUDAPEST, Hungary, Jan. 17, 2017 /PRNewswire/ -- Allergan Plc (AGN) and Gedeon Richter Plc. today announced positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women with abnormal bleeding due to uterine fibroids.  A new drug application filing for ulipristal acetate is planned for the second half of 2017. "We are pleased with the favorable results of Venus II supporting the efficacy and safety profile of ulipristal acetate as shown in our Venus I trial," said David Nicholson, Chief Research and Development Officer, Allergan.

  • TheStreet.comyesterday

    Allergan, Schlumberger, IBM: Doug Kass' Views

    Doug Kass shares his thoughts on animal spirits, and discusses his astonishment at some rising optimism.

  • TheStreet.com3 days ago

    Jobless Claims and Trimming GLD: Best of Kass

    In highlights from this week's trading diary and posts, Kass tells us about how he's selling some Allergan shares and how he feels about the jobless claims.